Amyloid pterygium
ICD-10 H11.01 is a used to indicate a diagnosis of amyloid pterygium.
Amyloid pterygium is a rare ocular condition characterized by the deposition of amyloid protein in the conjunctiva, leading to the formation of a yellowish-white, gelatinous mass. This condition primarily affects the conjunctival tissue but can also involve the sclera and cornea, resulting in visual disturbances and discomfort. The disease progression is typically slow, with patients often presenting with asymptomatic lesions that may eventually cause irritation or cosmetic concerns. Diagnosis is primarily clinical, supported by histopathological examination of biopsy specimens showing amyloid deposits. Differential diagnoses include conjunctival cysts, pinguecula, and other conjunctival tumors. Regular monitoring is essential, as amyloid pterygium can sometimes be associated with systemic amyloidosis, necessitating a thorough evaluation of the patient's overall health status.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
H11.01 specifically covers amyloid pterygium, which is characterized by amyloid deposits in the conjunctiva. It is important to differentiate this from other conjunctival lesions such as pterygium, conjunctival cysts, and tumors.
H11.01 should be used when there is a confirmed diagnosis of amyloid pterygium, particularly when histological evidence of amyloid deposits is available. It is crucial to avoid using this code for other types of pterygium or conjunctival lesions without amyloid involvement.
Documentation for H11.01 should include a detailed clinical examination, patient history, and histopathological reports confirming the presence of amyloid deposits in the conjunctiva. Photographic evidence may also be beneficial.
